CENTRAL TRUST Co Sells 3,183 Shares of Cigna Group (NYSE:CI)

CENTRAL TRUST Co reduced its holdings in Cigna Group (NYSE:CI - Free Report) by 19.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,072 shares of the health services provider's stock after selling 3,183 shares during the period. CENTRAL TRUST Co's holdings in Cigna Group were worth $4,301,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Two Sigma Investments LP lifted its stake in shares of Cigna Group by 32.6% in the fourth quarter. Two Sigma Investments LP now owns 764,900 shares of the health services provider's stock valued at $211,219,000 after buying an additional 188,235 shares during the period. Valley Wealth Managers Inc. lifted its position in shares of Cigna Group by 2.8% in the 4th quarter. Valley Wealth Managers Inc. now owns 56,933 shares of the health services provider's stock worth $15,721,000 after acquiring an additional 1,548 shares during the period. Humankind Investments LLC lifted its position in shares of Cigna Group by 12.1% in the 4th quarter. Humankind Investments LLC now owns 5,294 shares of the health services provider's stock worth $1,462,000 after acquiring an additional 571 shares during the period. NBC Securities Inc. acquired a new stake in shares of Cigna Group during the 1st quarter worth approximately $123,000. Finally, Pine Valley Investments Ltd Liability Co increased its position in shares of Cigna Group by 10.5% during the fourth quarter. Pine Valley Investments Ltd Liability Co now owns 17,366 shares of the health services provider's stock valued at $4,796,000 after purchasing an additional 1,653 shares during the period. 86.99% of the stock is owned by institutional investors.

Cigna Group Price Performance

Cigna Group stock opened at $312.32 on Wednesday. Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The firm has a market cap of $83.43 billion, a P/E ratio of 17.29, a P/E/G ratio of 0.93 and a beta of 0.44. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.72 and a current ratio of 0.72. The business's fifty day moving average is $322.18 and its two-hundred day moving average is $308.05.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.35 by $0.39. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. The business had revenue of $65.45 billion for the quarter, compared to the consensus estimate of $60.39 billion. During the same quarter in the prior year, the company earned $6.47 EPS. The firm's quarterly revenue was up 14.4% on a year-over-year basis. Equities research analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd will be paid a $1.51 dividend. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 annualized dividend and a dividend yield of 1.93%. Cigna Group's dividend payout ratio (DPR) is currently 33.44%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on CI shares. Piper Sandler raised their target price on Cigna Group from $348.00 to $374.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. Robert W. Baird decreased their target price on shares of Cigna Group from $388.00 to $362.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. Truist Financial upped their target price on shares of Cigna Group from $385.00 to $405.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Wall Street Zen upgraded shares of Cigna Group from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, April 8th. Finally, Mizuho upped their price objective on Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Two research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Buy" and a consensus price target of $380.39.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.